American Century Companies Inc. Boosts Stake in Innospec Inc. $IOSP

American Century Companies Inc. raised its holdings in Innospec Inc. (NASDAQ:IOSP) by 17.5% during the 2nd quarter, HoldingsChannel.com reports. The fund owned 55,861 shares of the specialty chemicals company’s stock after acquiring an additional 8,316 shares during the quarter. American Century Companies Inc.’s holdings in Innospec were worth $4,697,000 at the end of the most recent reporting period.

A number of other large investors have also recently modified their holdings of IOSP. Blue Trust Inc. increased its position in shares of Innospec by 38.3% in the second quarter. Blue Trust Inc. now owns 672 shares of the specialty chemicals company’s stock worth $57,000 after purchasing an additional 186 shares during the last quarter. US Bancorp DE grew its stake in Innospec by 4.2% in the 1st quarter. US Bancorp DE now owns 5,082 shares of the specialty chemicals company’s stock worth $482,000 after buying an additional 207 shares in the last quarter. Hsbc Holdings PLC increased its holdings in shares of Innospec by 2.9% in the 1st quarter. Hsbc Holdings PLC now owns 7,398 shares of the specialty chemicals company’s stock worth $700,000 after buying an additional 208 shares during the last quarter. Baird Financial Group Inc. raised its position in shares of Innospec by 11.5% during the 1st quarter. Baird Financial Group Inc. now owns 2,170 shares of the specialty chemicals company’s stock valued at $206,000 after buying an additional 223 shares in the last quarter. Finally, Police & Firemen s Retirement System of New Jersey lifted its holdings in shares of Innospec by 6.0% during the 2nd quarter. Police & Firemen s Retirement System of New Jersey now owns 5,628 shares of the specialty chemicals company’s stock worth $473,000 after acquiring an additional 320 shares during the last quarter. Institutional investors own 96.64% of the company’s stock.

Innospec Trading Up 1.4%

Shares of Innospec stock opened at $75.04 on Monday. Innospec Inc. has a 12 month low of $70.10 and a 12 month high of $120.00. The firm has a market capitalization of $1.86 billion, a P/E ratio of -2,501.33 and a beta of 0.93. The business has a fifty day simple moving average of $74.74 and a two-hundred day simple moving average of $80.92.

Innospec (NASDAQ:IOSP) last issued its quarterly earnings results on Wednesday, November 5th. The specialty chemicals company reported $1.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.03 by $0.09. Innospec had a negative net margin of 0.07% and a positive return on equity of 10.28%. The company had revenue of $441.90 million during the quarter, compared to analyst estimates of $443.00 million. During the same period last year, the business earned $1.35 EPS. Innospec’s quarterly revenue was down .3% compared to the same quarter last year. Analysts predict that Innospec Inc. will post 6.18 earnings per share for the current year.

Innospec Dividend Announcement

The business also recently disclosed a dividend, which was paid on Wednesday, November 26th. Investors of record on Tuesday, November 18th were given a dividend of $0.87 per share. This represents a yield of 245.0%. The ex-dividend date of this dividend was Tuesday, November 18th. Innospec’s dividend payout ratio (DPR) is -5,800.00%.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the company. Weiss Ratings restated a “sell (d)” rating on shares of Innospec in a research report on Thursday. Zacks Research lowered shares of Innospec from a “hold” rating to a “strong sell” rating in a report on Tuesday, November 4th. Finally, Wall Street Zen cut Innospec from a “buy” rating to a “hold” rating in a report on Sunday, October 19th. One equities research analyst has rated the stock with a Strong Buy rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold”.

Insider Activity

In other news, Director Leslie J. Parrette bought 340 shares of the company’s stock in a transaction dated Friday, November 14th. The shares were purchased at an average price of $74.09 per share, for a total transaction of $25,190.60. Following the completion of the purchase, the director owned 5,837 shares in the company, valued at approximately $432,463.33. This represents a 6.19% increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 1.31% of the stock is currently owned by corporate insiders.

Innospec Company Profile

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.